Currently, little is known about histone modifications and molecular mechanisms of negatively regulated transcription. In pituitary cells, thyroid hormone (T 3 ) decreased transcription, and surprisingly increased histone acetylation, of TSH␣ promoter. This increase was mediated directly by thyroid hormone receptor. Histone acetylation of H3K9 and H3K18 sites, two modifications usually associated with transcriptional activation, occur in negative regulation of TSH␣ promoter. T 3 also caused release of a corepressor complex composed of histone deacetylase 3 (HDAC3), transducin ␤-like protein 1, and nuclear receptor coprepressor (NCoR)/ silencing mediator for retinoic and thyroid hormone receptor from TSH␣ promoter in chromatin immunoprecipitation assays. NCoR and HDAC3 overexpression selectively increased ligand-independent basal transcription. Two histone acetyltransferase inhibitors increased overall transcription but did not abrogate negative regulation or NCoR/HDAC3 complex release by T 3 . Chromatin immunoprecipitation analyses of an endogenous positively regulated target gene showed increased histone acetylation and corepressor complex release with T 3 treatment. Finally, microarray analyses suggested there is a subset of negatively regulated genes with increased histone acetylation. These findings demonstrate the critical role of NCoR/HDAC3 complex in negative regulation of TSH␣ gene expression and show that similar complexes and overlapping epigenetic modifications can participate in both negative and positive transcriptional regulation. (Molecular Endocrinology 23: 600 -609, 2009)
Currently, little is known about histone modifications and molecular mechanisms of negatively regulated transcription. In pituitary cells, thyroid hormone (T 3 ) decreased transcription, and surprisingly increased histone acetylation, of TSH␣ promoter. This increase was mediated directly by thyroid hormone receptor. Histone acetylation of H3K9 and H3K18 sites, two modifications usually associated with transcriptional activation, occur in negative regulation of TSH␣ promoter. T 3 also caused release of a corepressor complex composed of histone deacetylase 3 (HDAC3), transducin ␤-like protein 1, and nuclear receptor coprepressor (NCoR)/ silencing mediator for retinoic and thyroid hormone receptor from TSH␣ promoter in chromatin immunoprecipitation assays. NCoR and HDAC3 overexpression selectively increased ligand-independent basal transcription. Two histone acetyltransferase inhibitors increased overall transcription but did not abrogate negative regulation or NCoR/HDAC3 complex release by T 3 . Chromatin immunoprecipitation analyses of an endogenous positively regulated target gene showed increased histone acetylation and corepressor complex release with T 3 treatment. Finally, microarray analyses suggested there is a subset of negatively regulated genes with increased histone acetylation. These findings demonstrate the critical role of NCoR/HDAC3 complex in negative regulation of TSH␣ gene expression and show that similar complexes and overlapping epigenetic modifications can participate in both negative and positive transcriptional regulation. (Molecular Endocrinology 23: 600 -609, 2009) T hyroid hormone receptors (TRs) belong to a superfamily of nuclear hormone receptors that act as ligand-regulatable transcription factors (1, 2). There are two major TR isoforms, TR␣ and TR␤, encoded on separate genes. TRs bind to thyroid hormone response elements in the promoters of target genes to regulate their transcription. In positively regulated target genes, unliganded TRs bind to corepressors such as nuclear receptor corepressor (NCoR) or silencing mediator for retinoic and thyroid hormone receptors (SMRT) that form corepressor complexes containing transducin ␤-like protein 1 (TBL1) and histone deacetylase 3 (HDAC3), and mediate basal transcriptional repression by unliganded thyroid hormone receptor in positively regulated target genes (3) (4) (5) . In the presence of T 3 , corepressor complexes are released from liganded TRs that, in turn, associate with coactivator complexes that contain steroid receptor coactivator (SRCs), cAMP response element-binding protein (CREB)-binding protein (CBP), and P/CAF. These complexes cause increased histone acetylation near the TRE of the promoter (1, 2, 6) . ATP-dependent chromatin remodeling complexes similar to the SWI/SNF family in yeast that contains the adenosine triphosphatase subunit, Brahma-related gene 1, also are recruited to the promoter (7, 8) and critical for transcrip-tional activation. Another major complex, Mediator complex, also can interact with the promoter and serves to recruit RNA polymerase II (RNA pol II) (9 -11) . Recently, chromatin immunoprecipitation (ChIP) studies have suggested that liganded TRs and nuclear hormone receptors recruit coactivators in a cyclical pattern on the promoters of some target genes (12) (13) (14) (15) (16) .
In contrast to positively regulated target genes, negatively regulated genes can be stimulated in the absence of T 3 and decreased by its presence. The mechanism(s) for negative transcriptional regulation by T 3 is not well understood; however, corepressors and coactivators may be involved. NCoR and SMRT can increase basal transcription of some target genes in the absence of T 3 (17) (18) (19) (20) . Coactivators also can play an apparently paradoxical role in T 3 -dependent negative regulation of some target genes (21) . On the other hand, it appears that HDACs are recruited by TRs during ligand-dependent negative regulation in other cases (22) . Thus, cofactor-associated changes in histone acetylation, and alterations in chromatin structure, may be involved in T 3 -mediated negative regulation. Of note, not all negatively regulated target genes are activated in the absence of ligand, suggesting that cofactors may be differentially recruited to promoters of negatively regulated target genes (23) .
TSH is a heterodimer composed of two subunits: TSH␣ and TSH␤. TSH␣, known as glycoprotein hormone ␣ common subunit, also is a subunit for several other glycoprotein hormones such as LH, FSH, and human choriogonadotropic hormone, whereas TSH␤ is unique to TSH. T 3 negatively regulates TSH by decreasing both TSH␣ and TSH␤ gene as well as TRH gene transcription (17, 19, 20) . These genes have been studied as models of negatively regulated gene transcription by T 3 . From a physiological perspective, their negative regulation is critical for feedback control of the hypothalamic/pituitary/thyroid axis.
To better understand the mechanism for negative regulation of gene transcription by T 3 , we established a pituitary cell line in which stably expressed luciferase was under the control of the TSH␣ promoter and negatively regulated by T 3 . This line was generated because there currently are no cell culture models for TSH␣-negative regulation, and endogenous TSH␣ is not expressed in GH3 cells. Surprisingly, the negative regulation of TSH␣ is associated with increased histone acetylation of the TSH␣ promoter. The mechanism for this negative regulation is dependent upon corepressor and HDAC3 release from the promoter. Our findings show that histone acetylation occurs in positively, as well as negatively, regulated target genes via overlapping molecular mechanisms and suggest that histone acetylation of the promoter per se in not sufficient to predict the direction of transcription in a given target gene.
Results

Establishment of a stable rat pituitary GH 3 cell line
We generated a stable rat pituitary GH 3 cell line, ␣-23, containing the human TSH␣ promoter (Ϫ840 to ϩ1) in tandem with a luciferase reporter cDNA to study negative regulation by T 3 in a native chromatin context. This construct was shown previously to be sufficient for negatively regulated transcription by T 3 in transient transfection studies (24) . As expected, ␣-23 cells exhibited a dose-dependent decrease in luciferase activity by T 3 (Fig. 1A) . A decrease was observed at 1 nM T 3 and a maximal decrease (ϳ90%) was seen at 0.1 M T 3 (Fig. 1A ). These results demonstrate that the stably integrated TSH␣ promoter is negatively regulated by T 3 in the GH 3 cells, and mimics the ligand-dependent negative-feedback regulation of the TSH␣ gene by the pituitary in vivo. We found minimal expression of endogenous TSH␣ gene in the absence or presence of T 3 by microarray analyses and quantitative RT-PCR so it apparently is silenced in parent GH 3 cells. 
Inhibition of TSH␣ promoter activity by trichostatin A (TSA)
We next examined the effects of the histone deacetylase inhibitor, TSA, and T 3 on luciferase activity in ␣-23 cells. Surprisingly, TSA inhibited luciferase activity in ␣-23 cells in a dosedependent fashion, suggesting that negative transcriptional regulation by the TSH␣ promoter is mediated by histone acetylation (Fig. 1B) . Indeed, TSA stimulated histone acetylation of TSH␣ promoter in ChIP assay (data not shown). Moreover, because coadministration of T 3 with TSA led to only a slightly further decrease in transcription, T 3 -mediated negative regulation of TSH␣ may occur by the same mechanism as TSA, i.e. histone acetylation. At 1 h, T 3 also negatively regulated luciferase mRNA from TSH␣ promoter (Fig. 1C) .
Histone H3 acetylation of the TSH␣ promoter after T 3 treatment
To examine whether T 3 induced histone acetylation of TSH␣ promoter, we performed ChIP assay. T 3 induced a rapid time-dependent increase in histone H3 acetylation of the TSH␣ promoter that could be detected after 15 min but did not significantly change histone H4 acetylation (Fig. 2 , A-C). Thus, T 3 increased histone acetylation of a negatively regulated target gene.
Histone acetylation of TSH␣ promoter mediated directly by TR
These unexpected findings prompted us to investigate further the mechanism of histone acetylation. To increase histone acetylation on TSH␣ promoter, we transiently transfected ␣-23 cells with a vector encoding VP16/TR␤, a dominant positive fusion protein containing the activation domain of Herpes simplex 1 virus (VP16) fused to the amino terminus of full-length human TR␤ (Fig. 3〈) . Previous studies have shown that this fusion protein had constitutive transcriptional activity in positively regulated target genes associated with increased histone acetylation (25) . In the case of the TSH␣, VP16/TR␤ further decreased transcriptional activity both in the absence and presence of T 3 while still exhibiting negative regulation by T 3 (Fig. 3B) . Significantly, ChIP analysis showed that VP16/TR␤ mediated increases in histone H3 acetylation that were associated with decreased TSH␣ gene transcription both in the absence and presence of hormone (Fig. 3B) , although there was a net increase in histone acetylation in the latter (Fig. 3, C and D) . These findings further suggest that decreased transcriptional activity by the TSH␣ promoter is associated with increased histone acetylation. Moreover, they also strongly suggest that TR complex directly mediates the histone acetylation changes on the promoter by T 3 in a cis manner as recruitment of another enhancer, namely the dominant positive VP16/TR, led to a T 3 -dependent increase in histone H3 acetylation that was associated with a concomitant decrease in transcriptional activity.
Dissociation of cofactors from TSH␣ promoter after T 3 treatment
We next investigated the cofactors that participated in the T 3 -dependent histone acetylation of TSH␣ promoter by ChIP analysis (Fig. 4A) . TR␤ bound to TSH␣ promoter in both the absence and presence of T 3 , although its binding increased with T 3 treatment. NCoR, SMRT, TBL1, and HDAC3 also bound to TSH␣ promoter in the absence of hormone; however, in contrast to TR␤, their binding decreased with T 3 treatment. These proteins previously were shown to form a corepressor complex in positively regulated target genes (3) (4) (5) . Moreover, HDAC3 appears to be a specific part of the corepressor complex that dissociated upon T 3 treatment because no changes in HDAC1 or HDAC2 binding to the promoter were observed. Consistent There was no additional recruitment of SRC-1 coactivator with T 3 treatment (Fig.  4A) . Similar findings also were observed for SRC-2, SRC-3, CREB-binding protein (CBP)/p300 and P/CAF (data not shown). Taken together, our ChIP findings are not only consistent with the observed increase in histone H3 acetylation after T 3 treatment but also suggest that the release of corepressors, NCoR and SMRT, as well as HDAC3 after T 3 treatment, rather than the recruitment of known p160 coactivators and CBP with histone acetyltransferase activity, contribute to the observed increase in histone acetylation. Additionally, receptor-interacting protein 140, a coregulator that blocks steroid receptorand TR-mediated transcriptional activity as well as recruits HDACs and histone methyltransferases (26 -28), did not change its binding to the TSH␣ promoter in the absence or presence of T 3 .
Effects of NCoR and HDACs on TSH␣ promoter basal activity
To determine whether corepressors and HDAC3 had specific functional roles on the negative-regulation of TSH␣ gene, we examined the effects of NCoR and HDAC overexpression on TSH␣ promoter activity in transient transfection assays. Both NCoR and HDAC3 overexpression induced a significant increase in basal transcription in the absence of T 3 and fold repression (ratio of basal transcription level/ ligand-dependent transcription level). The HDAC3 effect was specific because HDAC1 and HDAC2 overexpression had no significant effects on either basal transcription level or fold repression (Fig. 4B) . The increased transcriptional activity by NCoR and HDAC3 overexpression was associated with decreased histone H3 acetylation (Fig. 4C ).
Effects of P/CAF and CBP/300 HAT inhibitors on TSH␣ promoter transcriptional activity
To further examine the role of corepressors and HDAC3 in mediating negative regulation, we examined the effects of two specific peptide histone acetyl transferase (HAT) inhibitors on TSH␣ promoter activity: Lys-coenzyme A (CoA) for CBP/p300 and H3-CoA for P/CAF (6) (Fig. 5A ). These two inhibitors increased basal transcription levels in the absence and presence of T 3 , presumably by decreasing histone acetylation. However, T 3 -mediated negativeregulation still occurred when cells were treated with these HAT inhibitors, albeit at a higher set point than cells treated with control peptide. Interestingly, whereas H3-CoA led to higher transcription levels, it also was associated with decreased histone H3 acetylation Fig. 1 . Shown are the mean of triplicate samples Ϯ SD normalized to control as 100%. Similar findings were found in two other experiments. *, P Ͻ 0.05 difference from control using ANOVA. C, Quantitative RT-PCR analyses of PCR products from using anti-acetyl H3 antibody (n ϭ 3). ␣-23 cells were treated for 1 h with T 3 before harvest for ChIP assay. Statistical analyses were performed as in Fig. 2 . #, P Ͻ 0.05; *, P Ͻ 0.01 from untreated and treated controls, respectively, using ANOVA.
Mol org both in the absence and presence of T 3 . ChIP analysis showed T 3 -dependent release of NCoR and HDAC3 from the TSH␣ promoter even with concomitant H3-CoA treatment (Fig. 5C, lanes 3  and 4) . Taken together, these data provide further evidence for the importance of the corepressor complex loss in mediating negative regulation of the TSH␣ gene even though basal levels may be determined by overall histone H3 acetylation.
H3K9 and H3K18 are the sites for increased histone acetylation of TSH␣ promoter by T 3 We performed ChIP assay using site-specific antibodies against histone-acetylated lysines. H3K9 and H3K18 acetylation increased, whereas H3K14 was unaffected (Fig. 6, A and B) .
Thus, it appears that H3K9 and H3K18 are major contributors to histone H3 acetylation. Of note, H3K9 trimethylation decreased concomitantly with H3K9 acetylation.
Microarray analyses of genes that are coregulated by TSA and T 3
To determine whether increased histone acetylation could potentially be associated with negative regulation of other target genes by T 3 other than TSH␣, we performed microarray analysis of ␣-23 cells treated with T 3 for 0, 3, 6, and 15 h and TSA for 6 h. Triplicate samples were obtained for the T 3 -treated samples at each time point. RNA expression was measured using the Illumina rat ref 12 genome chip (Fig. 7A) . A total of 10,874 genes was expressed in ␣-23 cells. Among them, 1334 (12.2%) were up-regulated greater than 1.5-fold by TSA, and 1145 (10.5%) were negatively regulated greater than 60% by TSA. Forty nine genes were negatively regulated by T 3 at 15 h. Figure 7 shows gene expression of negatively regulated target genes (red to green over time) with a major cluster at the top (green with TSA) and a smaller one (red with TSA) on the bottom of the heat map, representing negative and positive regulation with TSA, respectively. Among the 49 negatively regulated target genes, 32 also were negatively regulated by TSA compared with only three that were up-regulated by TSA (Fig.  7B) Although it is not known definitively whether all these negatively regulated genes have increased histone acetylation of their promoters after T 3 addition, these findings are consistent, nonetheless, with the notion that there may be a subclass of negatively regulated target genes for which this occurs. Detailed studies of the histone acetylation of promoters of these genes would be needed to confirm this. Interestingly, among 72 positively-regulated target genes, 30 were down-regulated, five were up-regulated, and 37 were not regulated by TSA (supplemental Fig. 1 published as supplemental data on The Endocrine Society's Journals Online web site at http://mend. endojournals.org).
FIG. 5.
TSH␣ transcripitonal activity and corepressor complex binding after blocking with P/CAF and CBP/p300 HAT inhibitors. A, Effects of two HAT inhibitors on TSH␣ promoter activity. ␣-23 cells were seeded in 24-well plates and cultured in T 3 -free 10% FBS-DMEM medium for 3 d. Ten microliters of digitonin solution (50 mg/ml) were added to the wells 10 min before the addition of the HAT inhibitors, Lys-CoA and H3-CoA. T 3 (0.1 M) was added to the wells, and cells were cultured overnight. The cell lysates were prepared, and luciferase activities were measured as in Fig. 1 . Shown are the mean of triplicate samples Ϯ SD normalized to control as 100%. Similar findings were observed in two other experiments. *, P Ͻ 0.05 difference between indicated samples using ANOVA. B, Quantitative RT-PCR analyses of PCR products from using anti-acetyl H3 antibody (n ϭ 3). ␣-23 cells were treated with H3-CoA overnight as above and then treated for 1 h with T 3 before harvest for ChIP assay. Statistical analyses were performed as in Fig. 1 . *, P Ͻ 0.05. C, Effects of a HAT inhibitor on NCoR and HDAC3 binding to TSH␣ promoter. ␣-23 cells were grown in T 3 -free 10% FBS-DMEM for 3 d and then treated with P/CAF inhibitor, H3-CoA, and H3-AC (Con) overnight as in Fig. 4B . Cells then were treated for 1 h with 0.1 M T 3 before harvest, and ChIP assay was performed as described in Materials and Methods using NCoR and HDAC3 antibodies. Similar findings were observed in two other experiments.
FIG. 6.
ChIP assays of specific histone H3 acetylation sites on the TSH␣ promoter. ␣-23 cells were treated for 1 h with T 3 before harvest for ChIP assay. A, PCR products from ChIP assay using indicated anti-acetyl H3 antibodies. Shown are bands from gel electrophoresis. Similar findings were observed in two other experiments. B, Quantitative RT-PCR analyses of PCR products from using anti-acetyl H3K9 and H3K18 antibodies (n ϭ 3). Statistical analyses were performed as in Fig. 1 . *, P Ͻ 0.05.
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The latter findings suggest that there may be some genes positively regulated by T 3 associated with decreased histone acetylation.
Corepressor complex release from positively regulated target gene promoters Previously, we found that T 3 increased acetylation of histone H3 and H4 on the promoters of endogenous target genes, including phosphoenolpyruvate carboxykinase (PEPCK) in GH 3 rat pituitary cells (16) . These effects were associated with cyclical recruitment of p160 coactivators. Currently, little is known about corepressor recruitment to endogenous target genes that are positively regulated by T 3 . We thus examined NCoR, SMRT, and HDAC3 binding to the PEPCK promoter in the absence and presence of T 3 by ChIP assay (Fig. 8A) . Similar to negatively regulated TSH␣, T 3 induced NCoR, SMRT, and HDAC3 release from the PEPCK promoter (Fig. 8A) . Both histone H3 and H4 acetylation of the PEPCK promoter also increased; however, in contrast to TSH␣ promoter, RNA pol II binding to the PEPCK promoter increased. A control study showed that PEPCK mRNA increased after 1 h of T 3 treatment (Fig. 8B) . Similar findings also were observed in two other positively regulated target genes, cholesterol 7␣ hydroxylase (cyp7) and sarcoplasmic endoplasmic reticulum calcium-adenosine triphosphatase in which we previously characterized their coactivator recruitment pattern to their promoters (data not shown) (16) . These findings suggest that T 3 -mediated dissociation of corepressor complex from TSH␣ promoter is similar to its dissociation from positively regulated target genes even though it leads to an opposite effect on transcriptional activity.
Discussion
Previous studies have shown that transcriptional activation is associated with increased histone acetylation (1, 2). Our current study demonstrates that T 3 -mediated negative regulation of the TSH␣ gene also is associated with increased histone H3 acetylation in a rat pituitary cell line. This surprising finding suggests that increased histone acetylation does not inevitably lead to transcriptional activation but also can be associated with transcriptional repression in some instances. Of note, it also has been reported that TSA can block transcriptional activation of the mouse mammary tumor virus promoter by progesterone, suggesting that histone acetylation per se is not always correlated with increased transcription (29) .
Our studies also showed that the corepressor complex that is commonly found on positively regulated target genes plays an important role in mediating negative regulation of TSH␣ gene and contributes to the increased histone acetylation (Fig. 7) . NCoR, SMRT, HDAC3, and TBL1 bind to the TSH␣ promoter in the absence of T 3 . The corecruitment of TBL1 suggests the formation of a corepressor complex on the TSH␣ promoter because TBL1 has been shown to interact preferentially with hypoacetylated histones to help stabilize the NCoR-HDAC3 complex on chromatin (30) . In this case, "corepressor complex" is actually a misnomer because it is associated with ligand-independent transcription and will be referred to as NCoR-HDAC3 complex. Similar to corepressor complexes that cause repression of many positively regulated target genes in the absence of T 3 (5, 31), NCoR-HDAC3 complex on the TSH␣ promoter specifically contains HDAC3 rather than other HDACs. Moreover, specific overexpression of NCoR and HDAC3 led to increased basal transcriptional activity. CBP and P/CAF HAT inhibitors also increased ligand-independent activation and ligand-dependent transcription of TSH␣; however, they did not abrogate negative regulation by T 3 , and HAT inhibitor did not affect T 3 -mediated NCoR and HDAC3 release from the TSH␣ promoter. Currently, it is not known whether there are other activator proteins that may be recruited by NCoR-HDAC3 complex to TSH␣ promoter. We also observed decreased RNA pol II recruitment by T 3 was associated with decreased transcription. It is not known whether T 3 modulates other RNA pol II functions such as initiation, elongation, or termination to contribute to the decreased transcription.
Taken together, our findings show that T 3 -induced loss of the NCoR-HDAC3 complex from TSH␣ promoter may be the key switch for its negative transcriptional regulation (see Fig. 9 ). In this connection, NCoR appears to be involved in ligandindependent transcription of TRH and CD44, target genes that are negatively regulated by T 3 (32, 33) . Moreover, we previously observed that a dominant negative NCoR targeted to liver in transgenic mice decreased ligand-independent activation of the negatively regulated target gene, sialyltransferase in vivo (34) . The histone modifications of these negatively regulated target genes are not known; however, our microarray studies suggest that there may be a subset of target genes that undergo both negative regulation and histone acetylation after T 3 treatment (Fig. 7) . In the case of TSH␣ promoter, it appears histone acetylation occurs primarily on H3K9 and H3K18. These sites have generally been thought to be associated with transcriptional activation (35) ; however, our findings suggest that there may be examples where this is not the case. In particular, histone methylations and phosphorylations also may contribute to the overall transcriptional activity, and further characterization is being performed by our laboratory. Of note, we have observed that H3K4 is demethylated by T 3 (Wang, D., and P.M. Yen, unpublished results), and methylation at this site is often associated with transcriptional activation.
We also observed that NCoR, SMRT, and HDAC3 binding to the promoters of several positively regulated target genes (cyp7, PEPCK, and sarcoplasmic endoplasmic reticulum calcium-adenosine triphosphatase) is decreased after T 3 treatment in GH3 cells (Fig. 8 and our unpublished results) . These findngs are consistent with other studies of positively regulated target genes which also show that NCoR, SMRT, and HDAC3 can form a corepressor complex with TR in the absence of hormone (3) (4) (5) . In the presence of T 3 , this corepressor complex dissociates from the promoter whereas coactivators with HAT activity are recruited, most likely in a cyclical pattern (16) . Thus, T 3 -induced corepressor loss leading to histone acetylation seems to be a common feature of positively regulated target genes and the negatively regulated TSH␣ gene.
Previous studies in SRC-1 knockout mice and TR␤ activation function 2 domain mutant knockin mice suggest that coactivators may be important for negative regulation of TSH (36, 37) . Our data did not show significant recruitment of SRCs. CBP/p300, or P/CAF to the TSH␣ promoter. Still it is possible that P/CAF and CBP/p300 may make modest contributions to negative regulation (despite their lack of binding on ChIP assay) because the fold repression by T 3 slightly decreased after treatment with inhibitors (Fig. 5) . However, absolute transcription levels increased in both the absence and presence of T 3 , and negative regulation was maintained (Fig. 5) . Further evidence supporting a contributory role for HATs is our observation that VP16/TR␤ can increase histone acetylation and decrease transcription in the absence of ligand (Fig. 2) and also is known to recruit p300/CBP (38) . Although the loss of NCoR/HDAC3 binding appears to be sufficient to increase histone acetylation and mediate negative regulation of TSH␣, it is possible that an unknown HAT could still be recruited to TSH␣ promoter in the presence of T 3 (Fig. 9) . However, our studies with the HDAC inhibitor, TSA, suggest that decreased histone deacetylation is a critical feature of negative regulation of TSH␣ promoter (Fig. 1) .
Our findings that histone acetylation is involved in the negative regulation of TSH␣ gene contrast with earlier studies of TSH␣ promoter activity in transiently transfected human embryonal kidney cells (21) , which showed that T 3 caused deacetylation of histone H4. T 3 also has been shown to recruit HDACs to the TRH and TSH␤ promoters (22, 39) ; therefore histone deacetylation may also be an important mechanism for the negative regulation of other target genes by T 3 . Several groups have suggested that CREB or other positive transcription factors such as activator protein 1, Pit-1, and GATA may be involved in the negative transcriptional regulation by T 3 (21, 40 -42) . Furthermore, human TSH␣ promoter activity is positively regulated by T 3 and TSA in Xenopus oocytes (43) . Thus, it is possible that hormone-dependent changes in histone modifications observed on the TSH␣ promoter may depend on stable vs. transient transfection, costimulation by enhancers, as well as cell type-and gene-specific contexts.
In summary, our findings show that histone acetylation associated with loss of corepressor complex with HDAC3 from the promoter can occur not only in positive regulation of transcription by T 3 but also in negative regulation. Thus, histone acetylation of the promoter by itself in not sufficient to predict the direction of transcription in a given target gene. It also is likely that similar events may occur in other target genes that are negatively regulated by nuclear hormone receptors and transcription factors. Our findings show that employment of similar epigenetic modifications and transcription complexes can lead to opposite transcriptional consequences in positively and negatively regulated target genes and, thus, shed light on the complexity, flexibility, and diversity of changes in the promoter that determine the ultimate direction of gene expression.
Materials and Methods
Reagents
Trichostatin A (TSA) was purchased from Upstate Biotechnology, Inc. (Lake Placid, NY). H3-AC-20 control, H3-CoA-20, Lys-CoA peptides have been previously described (6) . cDNAs for human NCoR, HDAC1, HDAC2, and HDAC3 were cloned into pcDNA 3.1 plasmids (Invitrogen, Carlsbad, CA). 
Antibodies
Establishment of ␣-23 cell line
A luciferase reporter construct under the control of the TSH ␣-subunit promoter (Ϫ840 to ϩ1), pGL2/ TSH␣-840, was kindly given by Dr. Larry Jameson (Northwestern University School of Medicine,) (24) . pGL2/ TSH␣-840 was mixed with pEGFPc1 (CLONTECH Laboratories, Inc., Palo Alto, CA) (4:1 ratio) and used to transfect rat pituitary GH3 cells, and selectively cultured in the presence of G418 (1 mg/ml). Resistant clones were expanded in G418 medium and analyzed for negative-regulation luciferase activity by 0.1 M T 3 with the clone (␣-23) exhibiting the highest amount of inhibition chosen for further study.
Cell culture, transient transfection, and reporter analyses
Monolayer cultures of clone ␣-23 cells were grown in DMEM (Life Technologies, Inc., Gaithersburg, MD) supplemented with 10% heatinactivated fetal calf serum (Biofluids, Rockville, MD) and maintained in 5% CO 2 atmosphere at 37 C. Cells were transfected with 300 ng DNA/well in 12-well plates with Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. Cell culture media were changed 6 h after transfection to antibiotic-free DMEM plus 10% charcoal-dextran-treated fetal bovine serum. T 3 was added to the cells 48 h later, and cells were harvested, lysed and assayed for reporter gene activity the next day using dual luciferase assay reagents according to the manufacturer's instructions (Promega Corp., Madison, WI).
Chromatin immunoprecipitation (ChIP) assay
ChIP assay was performed as previously described (16) . Briefly, ␣-23 cells were grown to 90% confluence in phenol red-free DMEM supplemented with 10% charcoal DEXTRAN-stripped fetal bovine serum (FBS) for at least 3 d. After addition of 10 Ϫ6 M T 3 at various time intervals, ChIP assays were performed according to manufacturer's protocol (Upstate Biotechnology) with some minor modifications. After treatment with T 3 , chromatin was cross-linked in 1% formaldehyde in PBS, and nuclei were extracted. Chromatin was sonicated to yield 500-to 1000-bp DNA fragments, and the supernatant containing precleared chromatin was then incubated at 0 C overnight with different antibodies or rabbit IgG control. After reverse cross-linking by heating the samples at 65 C overnight, and treating with Proteinase K, DNA was purified by QIAGEN PCR Purification Kit (QIAGEN, Chatsworth, CA) per manufacturer's instructions. PCR was performed to visualize the enriched DNA fragments using primers that amplify the promoter region of TSH␣ in pGL2/TSH␣ Plasmid and endogenous rat PEPCK promoters were previously described (16, 21) . Conventional PCR signals stained with ethidium bromide in 2% agarose gels.
Real-time PCR
For quantitative real-time PCR of ChIP products, we employed the SYBR green system (Applied Biosystems) using an Applied Biosystems 7300 sequence detector. We used the same sets of primers as conventional PCR and confirmed that the set of the primers for the real-time PCR yielded a single peak in the 40-cycle procedure. Relative values (mean Ϯ SD) normalized to input levels were compared with those obtained with IgG.
Microarrays
Triplicate samples of RNA from separate ␣-23 cell wells were isolated, labeled, hybridized, and scanned from microarrays according to the manufaturer's protocol (Illumina Inc., San Diego, CA). The Illumina Rat Ref-12 expression BeadChip was used, which contains more than 22,000 probes selected primarily from the NCBI RefSeq database. Expressed genes were analyzed and normalized with the lumi and limma packages in R/Bioconductor software for data preprocessing and analysis. The vst method was used for data transformation and the rsv for normalization.
Nonexpressed genes were excluded if detected P values were greater than 0.01. Differentially expressed genes were selected if adjusted P values were less than 0.01 by BH method (44) and fold changes greater than 1.5-fold. Statistics were done with the limFit and eBayes methods in the limma package.
